Stroke incidence in adults aged 20–54 nearly doubled from 1993–1994 to 2020, driven largely by ischemic stroke, while 30-day fatality declined, according to new research.
|Articles|August 14, 2013
CPAP for Severe Obstructive Sleep Apnea: Does Discomfort Warrant Discontinuation?
Author(s)Karl Doghramji, MD
CPAP is first-line therapy for severe OSA but when patients complain about mask-related discomfort, what to do?
Advertisement
Continuous positive airway pressure (CPAP) therapy has just been prescribed for a 40-year-old woman who experiences severe obstructive sleep apnea (OSA) syndrome by her sleep physician. She returns to your office, following a week of CPAP use, and complains that she does not like using CPAP because the mask is uncomfortable.
What is the most appropriate next step?
A. Discontinue CPAP
B. Refer the patient for consideration of upper airway surgery
C. Ask the patient to return to her sleep physician’s CPAP clinic
D. Consider management with an oral appliance
E. Order a switch to a smaller mask
Advertisement
Related to this article
The FDA has approved insulin efsitora alfa-gobe (Onswik) for adults with type 2 diabetes.
New research links type 2 diabetes and genetic risk to MASLD cirrhosis before 50, warning age-based fibrosis scores can miss severe disease.
FDA updates sotatercept-csrk label with HYPERION data, showing earlier use cuts PAH clinical worsening risk 76% alongside background therapy.
A US laboratory study found that 29.5% of patients with Lyme antibodies were seropositive for at least 1 other tick-borne pathogen.
Lumateperone reduced acute mania symptoms by day 3 in a phase 3 bipolar 1 trial, according to Johnson & Johnson.
Endocrine Society statement highlights key research gaps on obesity drugs—who benefits, long-term dosing, safety, and measuring success beyond weight loss.
Finerenone wins FDA clearance for type 1 diabetes–related CKD, lowering albuminuria in FINE-ONE and opening a long-awaited treatment path.
Advertisement
Advertisement
Trending on Patient Care Online
1
GLP-1 RAs for Weight Management: A Primary Care Approach to Risk and Monitoring
2
Stroke Incidence Nearly Doubled Among Adults Younger Than 55 Over 3 Decades
3
Safety, Dosing, and Drug Interactions for Dextromethorphan-Bupropion in Agitation
4
FDA Approves Sotatercept-csrk Label Update for Newly Diagnosed PAH
5